Project Grant R41DA061907
Award Date
6/15/25
Completion Date
5/31/26
Dollars Obligated
$334K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award of $535,374 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research on the acute and long-term effects of cannabinoid exposure during critical periods of brain development. The University of Mississippi will use a zebrafish model system to investigate the impacts of tetrahydrocannabinol (THC) and cannabidiol (CBD) on neuroinflammation, gene/protein expression, cellular trajectories, and...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $268,470 to The RAND Corporation to study the impacts of cannabidiol (CBD) policies on substance use behaviors and outcomes in the United States. The key objectives are to: 1) analyze recent laws and regulations around medical CBD access, and how they fit into the broader marijuana policy landscape; 2) examine the effects of medical CBD...
This $397,829 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of an AI-based platform to discover new therapeutic options for substance use disorders (SUDs). The key objectives of the project are to: 1) create curated training datasets and machine learning models to accelerate drug discovery tasks, 2) identify mechanistic targets related to glucagon-like peptide 1 (GLP-1) receptor...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), with a CFDA number of 93.279 for the Drug Use and Addiction Research Programs, will provide $2,118,992 to the University of Miami to conduct research on the neural and psychiatric consequences of cannabis use in adolescents. The primary objective is to investigate the effects of cannabis, the most widely used illicit drug among teenagers, on reward and pain neurocircuits in adolescents with depression. The...
This $668,110 federal Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The intervention aims to increase young adults' knowledge of cannabis products, marketing, laws, and associated risks. The grant will support the refinement of the intervention content through focus groups...
This $1,742,971 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research to investigate the epigenetic regulation of HIV/SIV and cocaine-induced inflammasome activation, and the potential therapeutic benefits of combining cannabinoids with antiretroviral therapy. The key objectives are to: 1) Examine the epigenetic mechanisms underlying cannabinoid-mediated reduction of cocaine-induced...
This $242,310 Project Grant was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research to examine the mechanism by which the hormone corticosterone rapidly mobilizes the endocannabinoid 2-arachidonoylglycerol (2-AG) in the prefrontal cortex and how this relates to stress-induced relapse in substance use disorders. The research will utilize ex vivo electrophysiology, fiber photometry, and behavioral drug...
This $475,500 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to identify novel compounds that can enhance the effectiveness of naloxone in reversing fentanyl overdose and mitigate other fentanyl-mediated behaviors like reward, dependence, and tolerance. The primary objectives are to: 1) Screen a library of cannabidiol (CBD) analogs to identify potent negative allosteric modulators (NAMs) of...
This Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to study the impact of adolescent cannabis use on prefrontal cortex maturation and cognitive function. The $1,383,618 award, effective from January 1, 2025 to November 30, 2029, will fund research to investigate how cannabis-induced changes in microglia contribute to aberrant maturation of the medial prefrontal cortex and impaired executive...
The federal Project Grant award, totaling $398,137.00, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding supports the development of high-precision epigenetic therapeutics for opioid use disorder (OUD), a growing epidemic in the United States. The project aims to identify functional modulators of the neuronal G9A complex, which regulates DFosB expression under chronic opioid exposure, and to test the efficacy...